Advances in synthetic intelligence, biotechnology and using well being knowledge are extensively considered among the many most important technological leaps in healthcare in many years. The European Regional Development Fund and Region Västra Götaland at the moment are investing SEK 25 million in the Precision Platform, a brand new initiative designed to make it simpler to develop, take a look at and implement the following era of personalised options for prevention, diagnostics and remedy.
The Precision Platform is a key step in delivering the Agenda for Life Science in Western Sweden. It will strengthen collaboration, innovation capability and worldwide competitiveness in one of many area’s most strategically vital areas for future development.
Many of probably the most important breakthroughs happen on the intersection of various analysis disciplines, applied sciences and scientific specialties. To harness this potential, the Precision Platform is being established as a joint platform the place researchers, clinicians, firms and innovation companions can collaborate to develop improvements in precision well being.
The platform supplies a single level of entry to experience, analysis environments, scientific settings, testbeds, infrastructure and collaboration companions. Its objective is to shorten the trail from analysis and innovation to sensible implementation in healthcare.
The initiative is led by Sahlgrenska University Hospital in collaboration with the University of Gothenburg, Chalmers University of Technology and Sahlgrenska Science Park.
More personalised healthcare
Precision well being is about understanding every particular person’s distinctive situations for well being and illness. This creates new alternatives to determine well being dangers at an earlier stage, stop illness and supply extra personalised diagnostics and coverings.
Boubou Hallberg, Sahlgrenska University Hospital.
Photo: Paul Björkman
“We are facing one of the greatest technological advances in healthcare since the emergence of modern medicine. It paves the way for more preventive, precise and personalised healthcare. To ensure that these new opportunities benefit patients and the wider population, we need environments where research, healthcare and industry can develop new knowledge and solutions together. That is exactly the role the Precision Platform is designed to play,” says Boubou Hallberg, CEO of Sahlgrenska University Hospital.
Positioning Western Sweden
As a part of the initiative, two further strategic sources for analysis and innovation will likely be established.
The first is a Health Data Sandbox – a safe testing and computing setting the place researchers, firms and healthcare professionals can develop and consider AI-based scientific resolution help techniques, diagnostic instruments and different data-driven options.
The second is a pre-GMP laboratory that can strengthen the area’s capability to develop and scale up superior therapies, enabling a quicker journey from early-stage innovation to scientific software and commercialisation.
The general ambition of the Precision Platform is to determine Western Sweden as a number one innovation hub for precision well being by making a platform the place researchers, healthcare suppliers, firms and innovation actors can develop, take a look at and implement the following era of options for prevention, diagnostics and remedy.
The initiative will strengthen the situations for brand spanking new collaborations in analysis, improvement and innovation whereas making Western Sweden extra enticing to expertise, funding and worldwide partnerships. In the long run, it is going to assist enhance folks’s well being and place Western Sweden as one in every of Europe’s main ecosystems for precision well being.
Helena Lundberg Nilsson, Region Västra Götaland.
Photo: Catharina Fyrberg
“Western Sweden is well positioned to take a leading role in the development of precision health. Through the Precision Platform, we are strengthening the region’s attractiveness for investment, research excellence and innovative companies, while reinforcing our position as a leading life science region,” says Helena Lundberg Nilsson, Regional Director of Development, Region Västra Götaland.
Martin Nilsson Jacobi, Chalmers University of Technology.
Photo: Anna-Lena Lundqvist
Martin Nilsson Jacobi, President and CEO, Chalmers University of Technology:
“Precision health is a key area for Chalmers, where we combine strong expertise at the intersection of technology and life science. With the Precision Platform we are taking an important step forward together with our partners in the field, creating strong environments, for example through open testbeds provided by Chalmers Next Labs. This will benefit patients while strengthening the competitiveness of a key regional industry.”
Jenny Nyström, Sahlgrenska Academy on the University of Gothenburg.
Photo: Malini Arnesson
Jenny Nyström, Professor and Dean, Sahlgrenska Academy on the University of Gothenburg:
“The Precision Platform will give researchers, students and collaborative partners better opportunities to develop, test and bring new medical innovations into healthcare. The initiative is particularly important for the continued development of advanced therapy medicinal products (ATMPs), building on Western Sweden’s strong ecosystem in advanced therapies, health data, AI and precision medicine.”
Göran Hilmersson, Faculty of Science and Technology on the University of Gothenburg.
Photo: Johan Wingborg
Göran Hilmersson, Professor and Dean, Faculty of Science and Technology:
“This is an important initiative for us because precision medicine is an area where knowledge from the natural sciences plays a crucial role. Research in fields such as biology and chemistry forms an essential foundation for medical research, and in recent years our work has become increasingly integrated with precision medicine.”
Axel Wolf, Centre for Person-centred Care – GPCC, University of Gothenburg.
Photo: Johan Wingborg
Axel Wolf, Professor and Director, University of Gothenburg Centre for Person-centred Care – GPCC:
“Western Sweden has a unique combination of expertise that also includes person-centred care and patient involvement. This creates the conditions to develop solutions that are medically accurate, organisationally sustainable and socioeconomically valuable, where people’s experiences, resources and goals are translated into concrete decisions and actions throughout the entire innovation chain.”
Cecilia Edebo, Sahlgrenska Science park.
Photo: Sahlgrenska Science park
Cecilia Edebo, CEO, Sahlgrenska Science Park:
“To accelerate innovation, we must translate research and technological breakthroughs into real-world impact much faster. Sahlgrenska Science Park acts as a catalyst by making it easier for our many start-ups and industry partners to connect with researchers, healthcare providers and test environments through the Precision Platform. This provides faster access to the right expertise and infrastructure, enabling more innovations to be developed, tested and implemented in clinical practice – ultimately benefiting people while strengthening the Swedish life science sector.”